Stay updated on Setmelanotide Long Term Extension Trial Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide Long Term Extension Trial Clinical Trial page.

Latest updates to the Setmelanotide Long Term Extension Trial Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed; no other content changes.SummaryDifference0.3%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has added significant information regarding a facility, including its name and location, as well as new medical topics and a relevant clinical trial publication. However, it has removed several location-related terms and previous revision details.SummaryDifference4%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated to include a long-term extension trial of Setmelanotide for obesity associated with genetic defects, sponsored by Rhythm Pharmaceuticals, Inc. This includes detailed information about the study's objectives, eligibility criteria, and locations for participation.SummaryDifference100%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Setmelanotide Long Term Extension Trial Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide Long Term Extension Trial Clinical Trial page.